| Calendar of Event|
Event Title: Synaptic Autoimmunity: A New Model for Cognition, Behavior, and Psychosis
| Date: 1/22/2010
Time: 11:00 - 12:30pm|
|Place: NYS Psychiatric Institute - 1st Flr. Auditorium - 1051 Riverside Drive, NYC 10032|
Speaker: Philip R. Muskin, MD
Professor in Clinical Psychiatry, Columbia University
Sander Markx, MD
Fellow in Schizophrenia Research, Columbia University
Discussant: Josep Dalmau, MD, PhD
Associate Professor, Division of Neuro-oncology, University of Pennsylvania
Description: *ADULT PSYCHIATRY GRAND ROUNDS*
Sander Markx, MD attended medical school at the University of Amsterdam in The Netherlands. He did his residency in psychiatry at the New York
State Psychiatric Institute. Sander is currently a schizophrenia research fellow, working on human genetics and animal models of schizophrenia in the labs of Drs. Gogos and Karayiorgou.
He published several articles as a first author and has received a number of awards, including a Fulbright scholarship for studying the genetics of psychiatric illness.
Philip R. Muskin, MD is a Professor of Clinical Psychiatry at Columbia University, College of Physicians and Surgeons, and the Chief of Consultation-Liaison Psychiatry at NewYork-Presbyterian Hospital/ Columbia. Dr. Muskin is also a faculty member of the Columbia University Psychoanalytic Center for Training and Research.
Dr. Muskin has received many academic awards, including Outstanding Teacher of the Year at the New York State Psychiatric Institute (NYSPI) on three separate occasions, the Association for Academic Psychiatry Regional Teacher of the Year Award, the Society for Liaison Psychiatry award for outstanding contributions to the field of Consultation-Liaison Psychiatry, the Lifetime Achievement Award of the Association for Academic Psychiatry, a Presidential Commendation from the APA, the Alumni Award from the Columbia University Department of Psychiatry, the Alan Stoudemire Award from the Academy of Psychosomatic Medicine, and the Irma Bland Award for Residency Teaching from the APA.
In 1989 he founded the Trained Liaison Comforter Program at Columbia University Medical Center; a volunteer program that provides emotional support for families of patients in intensive care units.
Dr. Muskin has authored over 30 journal articles, reviews for 15 journals, written over 30 book chapters, and produced four videotapes/CDís and DVDís. He has edited two books on medical illness and mental health and one on terrorism.
He recently published How to Use Herbs, Nutrients and Yoga in Mental Health Care (Norton 2009) which was the award-Winner in the Health: Alternative Medicine category of the National Best Books 2009 Awards, sponsored by USA Book News.
He chaired the APA Council on Psychosomatic Medicine and chaired the APA Scientific Program Committee from 2001-2002.
Discussant: Dr. Josep Dalmau received his M.D. and Ph.D. from the Autonoma University of Barcelona in Spain where he also completed an internship in Internal Medicine and a residency in Neurology. He trained in Neuro-oncology at the Memorial Sloan-Kettering Cancer Center in New York where he was appointed to the faculty at the completion of his fellowship. Dr. Dalmau is currently Professor of Neurology at the University of Pennsylvania, School of Medicine, and the Director of the Neuro-oncology Laboratory. In addition to funding by the National Institutes of Health, Dr. Dalmau has received grants and awards from the Charles A. Dana Foundation, the American Cancer Society, the European and Japanese Neurological Societies, and the McKnight Neuroscience of Brain Disorders.
Dr. Dalmau is an active member of many organizations including the American Academy of Neurology, the American Neurological Association, the American Society of Clinical Oncology, the American Association for Cancer Research, the Spanish Society of Neurology, and the Society of Neuro-oncology, and serves on several editorial boards.
Dr. Dalmau has contributed to numerous medical textbooks and has published in leading journals including among others the New England Journal of Medicine, Journal of Clinical Oncology, Lancet Neurology, Brain Pathology, Annals of Neurology, Brain, and Cell. Dr. Dalmau is recognized for his research in paraneoplastic diseases and related autoimmune disorders of the nervous system. His recent work focuses on the identification and characterization of a novel group of disorders associated with antibodies against neuronal cell surface receptors or ion channels that result in alterations of memory, behavior, cognition and dementia.